RNA-based medicines can modulate gene expression, offering new ways to prevent, manage and treat disease at its source. These medicines are no longer limited to just the liver, but can also reach the brain, heart or muscles. siRNA therapies are also incredibly durable, providing months of benefit from a single injection. These breakthroughs could bring new hope for genetic conditions and neurodegenerative disorders while also making treatments more accessible and affordable. As this new era of medicine emerges, we’re challenged not only to marvel at what’s possible but also to decide how this could shape the future of society.
By designing RNA-based drugs that can control gene expression, scientists are opening entirely new frontiers in medicine. Yet the possibilities reach beyond medicine alone. From tackling genetic conditions to offering hope for neurodegenerative diseases, this breakthrough invites us to imagine a future where these advances in medicine could transform how we understand health, longevity, and the boundaries of human potential.
Why Participate?
As scientists present their breakthrough ideas on the main stage of the Falling Walls Science Summit in Berlin, we invite the audience to explore the societal and ethical dimensions of their work, both now and in the future.
Who can Participate
Anyone who is engaged and interested in the topic. We invite both guests of the Falling Walls Science Summit, as well as interested participants who cannot attend the Summit live. Sign up with your email and we'll include you in a lottery to win a 4-day Science Summit ticket!
Challenge Host
The Falling Walls Science Summit is the international, interdisciplinary, and intersectoral forum for global science leaders. Since 2009, the Falling Walls Science Summit has united the world’s greatest minds to break down barriers in science and innovation. We bring together global science leaders, business pioneers, and public sector visionaries to share knowledge, foster collaboration, and shape the future of the international innovation system—creating meaningful impact for humanity.
Challenge Context
This challenge is organised in the context of the Falling Walls Science Summit 2025. There will be a session at the Summit where this topic will be discussed in more detail, and answers gathered through this future canvas will be incorporated.
123 Ratings
When Genes Sing of Ageless Tomorrows
- Society transitions from reactive to preventive healthcare with widespread gene-based therapies.
- Personalized gene therapies are routine, preventing hereditary diseases from birth.
- Ethical debates arise over germline editing and human enhancement in healthcare innovations.
Imagine a future where the air hums with the promise of health and longevity, and every breath exudes vitality. Society stands on the brink of a healthcare revolution, poised to transcend the reactive and embrace the preventive, sculpted by the artistry of gene-based therapies. In this envisioned world, diseases are curtailed not at their onset, but at their genesis, ensuring lives are lived unfettered by the shadows of genetic predispositions.
In bustling cities and serene villages alike, personalized gene therapies have become as commonplace as summer rain, offering tailored treatments that delve deep into the very blueprint of life. Imagine newborns, greeted not by the specter of hereditary ailments, but with the promise of robust health, thanks to a single gene-editing treatment that secures their future against diseases like Cystic Fibrosis.
Hospitals evolve into wellness centers, focusing on preventing diseases rather than merely managing them. The fear of exorbitant medical expenses fades as RNA-based medicines become accessible to all, weaving a tapestry of equity across the economic landscape.
Yet, as the luminous path unfolds, society ponders the ethics of germline editing, debating the balance between combating genetic disorders and the temptation of human enhancement. In this future, innovation dances hand in hand with ethical discourse, crafting a world where health is a shared treasure, fostering eternal hope for generations yet to come.
When Tomorrow Breathes Genes of Transformation
- Gene-based treatments promise longevity but present ethical and social challenges in healthcare.
- Precision medicine increases healthcare inequalities, affecting affordability and access to advanced treatments.
- Humanity faces dilemmas of identity and morality amid technological and societal transformation.
Imagine a future where society navigates the intricate dance of technological advancements and societal impact, particularly in the realm of healthcare. In this world, gene-based treatments, once the domain of speculative fiction, have now become the harbinger of a new age. With the promise to extend human longevity and redefine what it means to lead a healthy life, these treatments herald an era fraught with both hope and ethical conundrums. Medical professionals, now interpreters of complex genetic data, guide individuals through a landscape where the distinction between healing and surveillance blurs.
Yet, as precision medicine thrives, it casts a long shadow, exacerbating divides between those who can afford these cutting-edge treatments and those who cannot. Societal values shift, placing a premium on sustainability and the wisdom of fairness across generations. Individuals grapple with questions of identity, pondering what aspects of humanity should be preserved or altered and to what extent life's tapestry should be redesigned. Communities come together, questioning the morality of eradicating certain conditions and the implications for diversity and acceptance.
In this world, humanity stands on a precipice, poised between the potential to optimize and the peril of dehumanization, collectively deciding what it means to be human amid profound change.